Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

49.08
-1.1500-2.29%
Post-market: 48.90-0.1800-0.37%19:32 EDT
Volume:1.49M
Turnover:73.66M
Market Cap:9.38B
PE:-11.99
High:50.73
Open:50.61
Low:48.84
Close:50.23
52wk High:51.86
52wk Low:21.72
Shares:191.17M
Float Shares:151.20M
Volume Ratio:0.69
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0935
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-41.96%
PB:-5.25
PE(LYR):-17.05

Loading ...

Neil Kumar, Chief Executive Officer, Reports Disposal of Common Shares of BridgeBio Pharma Inc

Reuters
·
Aug 23

BridgeBio Pharma's President and CFO, Thomas Trimarchi, Reports Disposal of Common Shares

Reuters
·
Aug 20

BridgeBio Pharma (BBIO) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
Aug 13

Helix Acquisition Corp. II Releases Proforma Financials Highlighting BridgeBio Oncology Therapeutics Merger

Reuters
·
Aug 13

Director Charles J. Homcy Reports Disposal of Common Shares in BridgeBio Pharma Inc

Reuters
·
Aug 13

CEO Neil Kumar Reports Disposal of BridgeBio Pharma Inc. Common Shares

Reuters
·
Aug 12

Mizuho Securities Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 11

BridgeBio Pharma Inc : Mizuho Raises Target Price to $64 From $60

THOMSON REUTERS
·
Aug 11

J.P. Morgan Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 09

Director Andrea Ellis Reports Disposal of BridgeBio Pharma Inc. Common Shares

Reuters
·
Aug 08

Evercore ISI Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 07

Leerink Partners Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 07

Scotiabank Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 07

BridgeBio Pharma (BBIO) Receives a Buy from Truist Financial

TIPRANKS
·
Aug 07

Bank of America Securities Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 07

BridgeBio Pharma Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Aug 07

BridgeBio price target raised to $57 from $55 at Scotiabank

TIPRANKS
·
Aug 06

Stock Track | BridgeBio Pharma Plummets 11.93% Pre-market on Wider-Than-Expected Q2 Loss

Stock Track
·
Aug 06

BridgeBio Pharma Inc : Leerink Partners Raises Target Price to $62 From $56

THOMSON REUTERS
·
Aug 06

BridgeBio Pharma, Inc. : Oppenheimer Raises Target Price to $61 From $60

THOMSON REUTERS
·
Aug 06